Skip to content

Clinnical Study on TEAM Regimen as Conditioning Therapy for Autologous Stem Cell Transplantation in Peripheral T-Cell lymphoma

Clinnical Study on TEAM Regimen as Conditioning Therapy for Autologous Stem Cell Transplantation in Peripheral T-Cell lymphoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108988
Enrollment
Unknown
Registered
2025-09-10
Start date
2025-09-10
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PTCL

Interventions

study group:TEAM Regimen

Sponsors

The FIrst Affiliated Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.18 = 3 × 10^6/Kg; 5.ECOG score <= 2 points; 6.No serious complications, such as liver failure, kidney failure, or heart failure; 7.Voluntarily sign a written informed consent form before experimental screening;

Exclusion criteria

Exclusion criteria: 1.Has undergone autologous hematopoietic stem cell transplantation; 2.Severe uncontrolled infection before transplantation; 3.Patients with severe organ dysfunction; 4.History of other active tumors; 5.Pregnant and reproductive age women must have a negative pregnancy test and agree to use effective contraceptive measures during the treatment period and within the following year; 6.Researchers believe that there are other situations that are not suitable for participating in this experiment;

Design outcomes

Primary

MeasureTime frame
Progression-free survival;

Secondary

MeasureTime frame
Safety;Overall survival;

Countries

China

Contacts

Public ContactHongyan Tong

The FIrst Affiliated Hospital, College of Medicine, Zhejiang University

hongyantong@aliyun.com+86 571 87236625

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026